Card-brand restrictions on peptide merchants are creating serious consequences throughout the payments industry. Learn how potential six-figure fines against acquiring banks and processors can lead to frozen funds, sudden account closures, and fewer processing options for peptide businesses.

As card brands pressure processors to decline or cancel peptide merchant accounts, 2nd Amendment Processing continues helping eligible businesses explore ACH and cryptocurrency payment options.

Mastercard has added transaction and volume fees for businesses classified as specialty merchants. In 2ndAP’s view, this is a pure money grab: the published guidance identifies new charges, but no new merchant-facing fraud-prevention service or measurable protection purchased by those fees.

Eli Lilly’s tirzepatide patent should not become a blanket ban on peptide processing. We examine Visa’s penalties, corporate pressure, and the growing threat of financial deplatforming.

Reliable payment processing is critical for peptide businesses. Learn how 2nd Amendment Processing helps peptide merchants overcome industry challenges with secure, scalable payment solutions. #ProcessWithPurpose